Related references
Note: Only part of the references are listed.Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience
Simon Tiberi et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs
Arundhati Maitra et al.
BRITISH MEDICAL BULLETIN (2016)
Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index
Sean Wasserman et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
Andreas H. Diacon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Sulfamethoxazole Susceptibility of Mycobacterium tuberculosis Isolates from HIV-Infected Ugandan Adults with Tuberculosis Taking Trimethoprim-Sulfamethoxazole Prophylaxis
Sam Ogwang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Meropenem-Clavulanic Acid Has High In Vitro Activity against Multidrug-Resistant Mycobacterium tuberculosis
L. Davies Forsman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacokinetics and Pharmacodynamics of Clofazimine in a Mouse Model of Tuberculosis
Rosemary V. Swanson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Primera serie de pacientes con TB-XDR y pre-XDR tratados con esquemas que incluyeron meropenem-clavulanato en Argentina
Domingo Palmero et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Mefloquine as a potential drug against multidrug-resistant tuberculosis
David Krieger et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China
H. Liu et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Repurposing-a ray of hope in tackling extensively drug resistance in tuberculosis
Arundhati Maitra et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
C. Kuaban et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis
Sandeep Tyagi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Primera serie de pacientes con TB-XDR y pre-XDR tratados con esquemas que incluyeron meropenem-clavulanato en Argentina
Domingo Palmero et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Intra- and Extracellular Activities of Trimethoprim-Sulfamethoxazole against Susceptible and Multidrug-Resistant Mycobacterium tuberculosis
L. Davies Forsman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis
Mathieu S. Bolhuis et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
A. Piubello et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Mechanisms of β-lactam killing and resistance in the context of Mycobacterium tuberculosis
Carl N. Wivagg et al.
JOURNAL OF ANTIBIOTICS (2014)
Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies
Thomas J. Hwang et al.
BMJ OPEN (2014)
Susceptibility Testing of Extensively Drug-Resistant and Pre-Extensively Drug-Resistant Mycobacterium tuberculosis against Levofloxacin, Linezolid, and Amoxicillin-Clavulanate
Imran Ahmed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In Vitro Susceptibility of Mycobacterium tuberculosis to Trimethoprim and Sulfonamides in France
Sirwan Muhammed Ameen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Efficacy of Nitazoxanide against Clinical Isolates of Mycobacterium tuberculosis
Kristina Shigyo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
WHO Group 5 Drugs and Difficult Multidrug-Resistant Tuberculosis: a Systematic Review with Cohort Analysis and Meta-Analysis
Kwok-Chiu Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
Suresh Solapure et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis
Noor Alsaad et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
Saverio De Lorenzo et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates
Peter C. W. Yip et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Trimethoprim/sulfamethoxazole susceptibility of Mycobacterium tuberculosis
N. Alsaad et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Is there a place for -lactams in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis? Synergy between meropenem and amoxicillin/clavulanate
Ximena Gonzalo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses
Walther H. Wernsdorfer et al.
MALARIA JOURNAL (2013)
Reappraising the use of β-lactams to treat tuberculosis
Sebastian G. Kurz et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters
J. Xu et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Susceptibility of Mycobacterium tuberculosis to sulfamethoxazole, trimethoprim and their combination over a 12 year period in Taiwan
Tsi-Shu Huang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients
Won-Jung Koh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Sulfamethoxazole enhances the antimycobacterial activity of rifampicin
Lubabalo Macingwana et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Tracy Dalton et al.
LANCET (2012)
Macrophages Sequester Clofazimine in an Intracellular Liquid Crystal-Like Supramolecular Organization
Jason Baik et al.
PLOS ONE (2012)
Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
Ben Gold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosis
Karen K. Y. Lam et al.
PLOS PATHOGENS (2012)
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis
T. Schon et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Mycobacterium tuberculosis and Sulfamethoxazole Susceptibility
Wendy Ong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability
Tawanda Gumbo
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis
Federico Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Dosing Regimens of Cotrimoxazole (Trimethoprim-Sulfamethoxazole) for Melioidosis
Allen C. Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Tuberculosis and Trimethoprim-Sulfamethoxazole
Pierre Forgacs et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades Resistance
Luiz Pedro S. de Carvalho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis
Jean-Emmanuel Hugonnet et al.
SCIENCE (2009)
Pharmacokinetic and pharmacodynamic properties of meropenem
David P. Nicolau
CLINICAL INFECTIOUS DISEASES (2008)
The development of pharmacokinetically enhanced amoxicillin/clavulanate for the management of respiratory tract infections in adults
Thomas M. File
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Thioridazine: resurrection as an antimicrobial agent?
H. K. R. Thanacoody
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Factors affecting drug concentrations and QT interval during thioridazine therapy
R. H. K. Thanacoody et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis
Marta Martins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients
Chonghua Li et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
The vitro efficacy of β-lactam and β-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis
I Dinçer et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid
DE Nix et al.
TUBERCULOSIS (2004)
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)
HR Winter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Intracellular pharmacodynamics of antibiotics
S Carryn et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis
D Ordway et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Resazurin microtiter assay plate:: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis
JC Palomino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
